View |
|
DRP-13016
|
Tranexamic Acid
|
Trantran
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection (I.V.)
|
-
|
Pharmax India Private Limited
|
India
|
Initial
|
17 November 2022
|
17 November 2027
|
View |
|
HRP-554
|
Povidone Iodine
|
None
|
4.5 mg/mL (0.45% w/v)
|
Throat Spray Solution
|
-
|
Kohl Industries Corporation.
|
Philippines
|
Initial (HR)
|
16 November 2022
|
16 November 2027
|
View |
|
DRP-13014
|
Paracetamol
|
None
|
500 mg
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial
|
17 November 2022
|
17 November 2027
|
View |
|
DRP-12944
|
Apixaban
|
None
|
5 mg
|
Film-Coated Tablet
|
-
|
Intas Pharmaceuticals Ltd.
|
India
|
initial
|
15 November 2022
|
15 November 2027
|
View |
|
DRP-12943
|
Apixaban
|
None
|
2.5 mg
|
Film-Coated Tablet
|
-
|
Intas Pharmaceuticals Ltd.
|
India
|
initial
|
15 November 2022
|
15 November 2027
|
View |
|
DR-XY48476
|
Leuprorelin Acetate
|
Luprodex
|
11.25 mg
|
Lyophilized Powder For Injection (IM/SC)
|
-
|
Bharat Serums and Vaccines Limited
|
India
|
Initial
|
18 November 2022
|
18 November 2027
|
View |
|
DRP-13034
|
Ascorbic Acid + Zinc+ Cholecalciferol (Vitamin D3)
|
None
|
500 mg (equivalent to 562.50mg Sodium Ascorbate)/ 20 mg (equivalent to 54.90 mg Zinc Sulfate
Monohydrate)/ 400 IU
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial (OTC)
|
22 November 2022
|
22 November 2027
|
View |
|
DRP-13029
|
Ascorbic Acid
|
None
|
500 mg
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
United Kingdom
|
Initial (OTC)
|
22 November 2022
|
22 November 2027
|
View |
|
DRP-13032
|
Ascorbic Acid (As Calcium Ascorbate) + Zinc (As Zinc Gluconate)
|
None
|
500 mg (equivalent to 605.2 mg Calcium Ascorbate)/ 4.3 mg (equivalent to 30 mg Zinc Gluconate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
United Kingdom
|
Initial
|
22 November 2022
|
22 November 2027
|
View |
|
DRP-13033
|
Ascorbic Acid (as Calcium Ascorbate) + Zinc (as
Zinc Sulfate Monohydrate)
|
None
|
500 mg (equivalent to 605.2 mg Calcium Ascorbate)/ 20 mg (equivalent to 55 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
United Kingdom
|
Initial
|
22 November 2022
|
22 November 2027
|
View |
|
DRP-13028
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine
Hydrochloride
(Vitamin B6)
+ Cyanocobalamin
(Vitamin B12)
|
None
|
100 mg/ 5 mg/ 50 mcg
|
Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial (OTC)
|
22 November 2022
|
22 November 2027
|
View |
|
DRP-13031
|
Ascorbic Acid + Zinc
|
None
|
600 mg/ 50 mg
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial (OTC)
|
22 November 2022
|
22 November 2027
|
View |
|
DRP-13030
|
Ascorbic Acid + Zinc
|
None
|
500mg/40mg
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial (OTC)
|
22 November 2022
|
22 November 2027
|
View |
|
DRHR-2166
|
Isopropyl Alcohol
|
Doctor J
|
70 mL/100 mL (70% v/v)
|
Topical Solution (with
moisturizer)
|
-
|
Kohl Industries Corporation
|
Philippines
|
Initial [Household Remedy]
|
16 November 2022
|
16 November 2027
|
View |
|
DRHR-2165
|
Ethyl Alcohol
|
Doctor J
|
0.7
|
Topical Solution
|
-
|
Kohl Industries Corporation
|
Philippines
|
Initial [Household Remedy]
|
16 November 2022
|
16 November 2027
|
View |
|
DR-XY48464
|
5% Dextrose In Water
|
A.N.B. D5W
|
Each 100mL contains: Dextrose 5g
|
Solution For IV Infusion
|
-
|
A.N.B. Laboratories Co., Ltd.
|
Thailand
|
Initial
|
14 November 2022
|
14 November 2027
|
View |
|
DRP-13013
|
Paracetamol
|
Rapamol 125
|
125 mg/5 mL
|
Oral Suspension
|
-
|
Rhydburg Pharmaceuticals Ltd.
|
India
|
Initial (OTC)
|
17 November 2022
|
17 November 2027
|
View |
|
DRP-9983
|
Omeprazole
|
Omepron
|
40 mg
|
Delayed-Release Capsule
|
-
|
Ajanta Pharma Limited
|
India
|
Automatic Renewal (reconstruction)
|
11 November 2022
|
06 September 2026
|
View |
|
DR-XY48463
|
Metformin hydrochloride
|
Metfor PR 1000.
|
1 g
|
Prolonged Release Tablet
|
-
|
USV Private Limited
|
India
|
Initial (Correction)
|
13 October 2023
|
14 November 2027
|
View |
|
DR-XY48450
|
Risperidone
|
None
|
1 mg
|
Orodispersible Tablet
|
-
|
Kusum Healthcare Pvt. Ltd.
|
india
|
Initial
|
17 November 2022
|
17 November 2027
|